High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases-Reference-Cited by-同舟云学术

High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases

Published:2022 Issue:7 Volume:3 Page:3251-3266
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Quiñones Vélez Gabriel¹²^ORCID,Carmona-Sarabia Lesly¹²^ORCID,Rivera Raíces Alondra A.²³^ORCID,Hu Tony⁴^ORCID,Peterson-Peguero Esther A.³^ORCID,López-Mejías Vilmalí¹²^ORCID

Affiliation:

1. Department of Chemistry, University of Puerto Rico, Río Piedras, San Juan, Puerto Rico, 00931, USA

2. Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, Puerto Rico, 00926, USA

3. Department of Biology, University of Puerto Rico, Río Piedras, San Juan, Puerto Rico, 00931, USA

4. Department of Chemistry and the Molecular Design Institute, New York University, 100 Washington Square East, New York, New York 10003-6688, USA

Abstract

Formation of nano-Ca@ZOLE with viable properties in terms of structure, dissolution, stability, binding, and cytotoxicity, to render it suitable for osteolytic metastasis therapy.

Funder

National Institutes of Health

National Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2022/MA/D1MA01127H

Reference42 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Cancer statistics, 2019